Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 6/20 | 0.61 |
| ▸ | ABL1 | P00519 | 1/20 | 0.49 |
| ▸ | BCR | P11274 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.48 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.48 |
| ▸ | FGFR2 | P21802 | 2/20 | 0.48 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | FLT3 | P36888 | 1/20 | 0.46 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4494493 | 0.89 | GSK3B (0.57) | GSK3BHDAC6FGFR1FGFR2FGFR3 | |
| SCHEMBL4496084 | 0.88 | GSK3B (0.60) | GSK3BABL1BCRHDAC6FGFR1 | |
| SCHEMBL4500881 | 0.87 | HDAC6 (0.62) | GSK3BHDAC6FGFR1FGFR2FGFR3 | |
| SCHEMBL4496882 | 0.87 | GSK3B (0.62) | GSK3BABL1BCRHDAC6FGFR1 | |
| SCHEMBL4503174 | 0.86 | HDAC6 (0.55) | GSK3BHDAC6FGFR1FGFR2FGFR3 | |
| SCHEMBL4480819 | 0.86 | GSK3B (0.61) | GSK3BABL1BCRHDAC6FGFR1 | |
| SCHEMBL4502157 | 0.86 | HDAC6 (0.51) | GSK3BHDAC6FGFR1FGFR2FGFR3 | |
| SCHEMBL4475921 | 0.85 | HDAC6 (0.53) | GSK3BHDAC6FGFR1FGFR2FGFR3 | |
| SCHEMBL4504223 | 0.84 | GSK3B (0.62) | GSK3BABL1BCRHDAC6FGFR1 | |
| SCHEMBL4491789 | 0.84 | GSK3B (0.62) | GSK3BABL1BCRHDAC6FGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632854-B2 | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | PFIZER ITALIA S.R.L. (IT) | 2009-12-15 | — | — | US | claimed |